traffic analytics Rx&D - Canada's Research Based Pharmaceutical Companies
  Rx&DAbout Rx&DPharmaceutical Community
PublicationsMedia CentreStakeholders & PartnershipsMember's Login
 
 
 
  Forgot Password?
  Account Application
Rx&D HomeFrançaisContact Us
Useful LinksSite Map
  Pharmaceutical Community

Code of Conduct - Question & Answers

13. Advisory Boards - April 2006

 Question 1:
Rx&D's Code of Conduct Section 13.4 - Number of Advisory Board members/consultants states that “Any advisory board/consultants panel may not include more than 20 health care professionals per meeting.”   Are the chairperson and the faculty of the meeting included in the limit of 20 health care professionals?

Response:
No, the health care professionals who compose the chair and the faculty of the advisory board or consultant panel are not included in the limit of 20 health care professionals, provided that the chair and faculty give neither advice nor guidance to the Member company in the context of these meetings.  It is important to recall the overall purpose of advisory boards/ consultant panels, as outlined in the Rx&D Guiding Principles: “Advisory boards and consultants are only to be used to gather scientific or commercial guidance.” 


Revised: June, 2006
 
 
Back to top

Home | About Rx&D | Pharmaceutical Community | Publications | Media Centre | Stakeholders & Partnerships
Useful Links | Français | Contact Us | Site Map

55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Tel.: (613) 236-0455 Reception Fax: (613) 236-6756
Strategic Affairs & Communications Fax: (613) 236-6861
Federal Affairs Fax: (613) 236-7919
© 2007 Rx&D Terms and Conditions of Use
All Rights Reserved